SCHEMBL28864922

SCHEMBL28864922

CC(C)(C)OC(=O)N(CCc1ccccc1)B1OC(C)(C)C(C)(C)O1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 5/20 0.40
▸ CTSK P43235 3/20 0.37
▸ CTSS P25774 1/20 0.37
▸ AKT1 P31749 2/20 0.36
▸ USP30 Q70CQ3 1/20 0.36
▸ HDAC3 O15379 1/20 0.36
▸ HDAC1 Q13547 1/20 0.36
▸ HDAC2 Q92769 1/20 0.36
▸ NCOR2 Q9Y618 1/20 0.36
▸ MEN1 O00255 2/20 0.35
▸ KMT2A Q03164 2/20 0.35
▸ NPC1 O15118 1/20 0.35
▸ RAB9A P51151 1/20 0.35
▸ TDP1 Q9NUW8 1/20 0.35
▸ HTT P42858 1/20 0.35
▸ CA12 O43570 1/20 0.35
▸ CA1 P00915 1/20 0.35
▸ CA7 P43166 1/20 0.35
▸ CA14 Q9ULX7 1/20 0.35
▸ TAAR1 Q96RJ0 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21356696 0.87 AKT1 (0.43) L3MBTL1CTSSAKT1USP30HDAC3
SCHEMBL29234321 0.82 KMT2A (0.34) L3MBTL1AKT1MEN1KMT2ANPC1
SCHEMBL27635300 0.77 F2 (0.46) HDAC3HDAC1HDAC2NCOR2
SCHEMBL26024955 0.76 USP30 (0.37) USP30HDAC1HDAC2
SCHEMBL1316483 0.76 USP30 (0.39) L3MBTL1AKT1USP30HDAC3HDAC1
SCHEMBL5141538 0.76 MEN1 (0.41) L3MBTL1MEN1KMT2AHTT
SCHEMBL1520414 0.75 ALOX5 (0.51) L3MBTL1CTSKCTSSAKT1MEN1
SCHEMBL7458715 0.75 MLYCD (0.50) L3MBTL1CTSKKMT2ATAAR1MLYCD
SCHEMBL21798444 0.75 L3MBTL1 (0.38) L3MBTL1CTSKCTSSHDAC3HDAC1
SCHEMBL3640549 0.74 AOC3 (0.47) L3MBTL1CTSKCTSSAKT1HDAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115052860-A Collagen 1 translation inhibitors and methods of use thereof 艾尼莫生物科技公司 2022-09-13 — — CN disclosed
Send feedback